MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 100 filers reported holding MYOVANT SCIENCES LTD in Q3 2022. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,166,910 | +50.2% | 43,283 | +0.1% | 0.00% | +100.0% |
| Q3 2022 | $777,000 | +51.8% | 43,252 | +5.0% | 0.00% | +100.0% |
| Q2 2022 | $512,000 | +24.0% | 41,192 | +32.9% | 0.00% | 0.0% |
| Q1 2022 | $413,000 | -71.6% | 31,000 | -83.9% | 0.00% | -80.0% |
| Q1 2020 | $1,454,000 | -51.4% | 192,589 | 0.0% | 0.01% | -28.6% |
| Q4 2019 | $2,989,000 | +367.8% | 192,589 | +56.7% | 0.01% | +250.0% |
| Q3 2019 | $639,000 | -42.5% | 122,885 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $1,112,000 | – | 122,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 142,065 | $2,924,000 | 4.61% |
| Tri Locum Partners LP | 321,101 | $6,608,000 | 1.64% |
| PFM Health Sciences, LP | 2,054,928 | $42,290,000 | 1.29% |
| Bellevue Group AG | 5,194,039 | $106,893,000 | 1.13% |
| Pier Capital, LLC | 554,779 | $11,417,000 | 1.08% |
| Opaleye Management Inc. | 249,800 | $5,141,000 | 0.76% |
| Evolution Wealth Advisors, LLC | 140,227 | $2,886,000 | 0.64% |
| Hennion & Walsh Asset Management, Inc. | 399,330 | $8,218,000 | 0.49% |
| Cormorant Asset Management, LP | 1,000,000 | $20,580,000 | 0.46% |
| Integral Health Asset Management, LLC | 65,000 | $1,338,000 | 0.38% |